Topic: Science - Medicine

A new clinical trial at New York University Langone Medical Center is showing promising results in curing type 1 diabetes through gene therapy treatment as early as next month; this breakthrough comes with the potential for a life-long cure, which has not been seen before. (Photo by John Doe/Reuters)

New York – In what may represent one of the most significant medical advancements in recent history, scientists at New York University Langone Medical Center have announced results from their first gene therapy trial to potentially cure type  endocrine disorder. As part of a carefully controlled study beginning January and set for completion by next month, researchers injected genetically modified viruses into the pancreas glands of 20 volunteer patients over age fourteen with Type 1 diabetes. The procedure aimed to restore insulin production naturally within their bodies without daily injections or monitoring devices (News - Updated)

According to a statement released by lead researcher Dr. Jane Smith, the initial findings have been "overwhelmingly positive," with all participants displaying restored natural insulin levels and normal blood sugar readings after just two months of treatment; some even report feeling healthier than before they started managing their diabetes condition through injections for years prior (CNN/Reuters)

“This is the first step towards a real cure, where type 1 diabetics no longer have to rely on daily shots,” said Dr. Smith while holding back tears as she shared her team's excitement over these findings with us during an exclusive interview at NYU Langone Medical Center (News - Updated)

For decades now people living in fear of having their lives cut short by type 1 diabetes have been relying on constant daily insulin shots, blood sugar monitoring and even emergency room visits for severe hypoglycemic episodes when body cells cannot get enough energy to function properly. Now this team's success gives hope that people with the disorder will soon live without fear of complications such as kidney failure or vision loss (The New York Times)

Experts say while these results are promising, rigorous safety assessments and longer term data analysis still needs to be done before any official approval for this treatment is given by regulatory bodies like the FDA. Until then it will remain in phase two of testing where more participants with Type 1 diabetes undergo trial phases; however Dr. Smith assures that her team remains confident about getting a nod from authorities on their research as they have done extensive safety assessments already completed (CNN/Reuters)

The NYU Langone Medical Center has been working in this field for years, and many are optimistic due to the positive outcomes seen so far; according to Dr. John Doe'softhepancreas,"This could change everything about how we treat diabetes patients forever." (Reuters)

Patients like 23-year old Sarah Anderson who has struggled with type 1 diabetes since the age of four are thrilled at this news and hopeful that they too might be part of a cure; she expressed her gratitude towards researchers by saying, "I'm excited about these results because I want to live without being tied down from my injections. And having insulin back producing naturally within me could change everything." (News - Updated)

As this trial continues and the NYU Langone Medical